Skip to main content
Journal cover image

Response 1 to pharmacogenetic screening to prevent carbamazepine-induced toxic epidermal necrolysis and Stevens-Johnson syndrome: A critical appraisal

Publication ,  Journal Article
Shen, CY; Chen, YT
Published in: British Journal of Dermatology
January 1, 2012

Duke Scholars

Published In

British Journal of Dermatology

DOI

EISSN

1365-2133

ISSN

0007-0963

Publication Date

January 1, 2012

Volume

166

Issue

1

Start / End Page

11 / 12

Related Subject Headings

  • Dermatology & Venereal Diseases
  • 3202 Clinical sciences
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Shen, C. Y., & Chen, Y. T. (2012). Response 1 to pharmacogenetic screening to prevent carbamazepine-induced toxic epidermal necrolysis and Stevens-Johnson syndrome: A critical appraisal. British Journal of Dermatology, 166(1), 11–12. https://doi.org/10.1111/j.1365-2133.2011.10759.x
Shen, C. Y., and Y. T. Chen. “Response 1 to pharmacogenetic screening to prevent carbamazepine-induced toxic epidermal necrolysis and Stevens-Johnson syndrome: A critical appraisal.” British Journal of Dermatology 166, no. 1 (January 1, 2012): 11–12. https://doi.org/10.1111/j.1365-2133.2011.10759.x.
Shen, C. Y., and Y. T. Chen. “Response 1 to pharmacogenetic screening to prevent carbamazepine-induced toxic epidermal necrolysis and Stevens-Johnson syndrome: A critical appraisal.” British Journal of Dermatology, vol. 166, no. 1, Jan. 2012, pp. 11–12. Scopus, doi:10.1111/j.1365-2133.2011.10759.x.
Journal cover image

Published In

British Journal of Dermatology

DOI

EISSN

1365-2133

ISSN

0007-0963

Publication Date

January 1, 2012

Volume

166

Issue

1

Start / End Page

11 / 12

Related Subject Headings

  • Dermatology & Venereal Diseases
  • 3202 Clinical sciences
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences